CVS Health Corporation (CVS)
New CVS Health CEO Shakes Up Management, Commits To Integrated Model
New CVS Health chief executive officer David Joyner promoted an internal executive, Prem Shah, as group president of the company and hired former UnitedHealth Group executive Steve Nelson to run Aetna, the nation's third largest health insurer.
Earnings Exchange: Supermicro, Novo Nordisk, CVS Health
Steve Grasso, CEO of Grasso Global, joins CNBC's 'The Exchange' to discuss outlooks on three stocks: Supermicro, Novo Nordisk, and CVS Health.
Wall Street looking for CVS to show execution plan
CVS Health's David Joyner is expected to address how he will better manage rising patient costs in the Medicare business than his predecessor when he tackles his first earnings call as CEO on Wednesday, particularly after rivals have shown progress on that front in recent financial reports.
Analysts Still Bullish on CVS Ahead of Earnings Despite Recent Stock Drop
CVS Health (CVS) will report third-quarter earnings before the market opens Wednesday after the pharmacy and health-care provider had a rocky October that included a CEO change and layoffs, among other cost-cutting moves.
Curious about CVS Health (CVS) Q3 Performance? Explore Wall Street Estimates for Key Metrics
Besides Wall Street's top -and-bottom-line estimates for CVS Health (CVS), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended September 2024.
Earnings Preview: CVS Health (CVS) Q3 Earnings Expected to Decline
CVS Health (CVS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
CVS Health (CVS) Stock Sinks As Market Gains: Here's Why
CVS Health (CVS) closed at $56.25 in the latest trading session, marking a -1.94% move from the prior day.
CVS Q3 Estimates Plunge Before Earnings Release: How to Play the Stock
CVS Health faces outpatient and supplemental benefits pressure within Health Care Benefits.
CVS Health Stock Dip: Undervalued And Ready For A Turnaround
CVS Health dropped ~10% following Q3 earnings, impacted by a $1.1B Medicare charge and a $1.2B restructuring charge. CVS's FY2024 EPS forecast is $6.47, down 26.01% YoY, reflecting financial challenges, but FY2025 recovery is projected at $7.30, up 13%. The company's revenue is estimated at $369.25 billion in 2024, with upward revisions suggesting optimism, projected to reach $386.28 billion by 2025.
CVS Health Corporation (CVS) is Attracting Investor Attention: Here is What You Should Know
Zacks.com users have recently been watching CVS Health (CVS) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
CVS's Karen Lynch was just ousted. Why women CEOs are 45% more likely to get fired than men.
At the present rate, it will take 81 years to achieve gender parity among the CEO class
Is It Worth Investing in CVS Health (CVS) Based on Wall Street's Bullish Views?
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.
